StockNow
Calendar
Log in
U.S. Markets

Novo Nordisk (NOVOB DC/NVO) now treats 5.6mln people for obesity, nearly double the number from a year ago, helping total diabetes and obesity patients reach approximately 48mln, according to the earnings call

ORIGINAL · NewsquawkNovo Nordisk (NOVOB DC/NVO) now treats 5.6mln people for obesity, nearly double the number from a year ago, helping total diabetes and obesity patients reach approximately 48mln, according to the earnings callRead originalHide original

Obesity sales grew 22% in Q3, with GLP-1 volume growth across geographies and accelerated rollout of the Wegovy pill and 7.2mg Wegovy HD.

StockNow breaking-news AI analysis

The breaking-news item reports patient figures, Q3 obesity-sales growth, GLP-1 volume growth, and accelerated product rollout; a separate article corroborates sales and geographic volume details.

News detail

Obesity sales grew 22% in Q3, with GLP-1 volume growth across geographies and accelerated rollout of the Wegovy pill and 7.2mg Wegovy HD.

1 stocks
NVONovo-Nordisk A/S$42.38Current price

What do investors think?

Curious what other investors think?Log in to see reactions and join the conversation.
Log in to view reactions

StockNow uses AI to translate and analyze information and does not guarantee its accuracy or completeness.

Today's market highlights

A selection of stories drawing attention in the market.

See more
U.S. Markets

[MARKET UPDATE] US equity futures move back into the green, reversing earlier losses following the Democratic sweep; ES was down as much as 1.4% overnight; Bitcoin also reversed earlier losses

Geopolitics

Iran's leader warns of a much broader response if the US repeats its aggression, while dismissing expectations of a change in US behaviour following the midterm elections, Fars reports; Tehran will not make concessions to the US

U.S. Markets

Uber Technologies Inc. (UBER) Q3 2026 (USD): Adj. EPS 0.88 (exp. 0.86), Revenue 14.8bln (exp. 14.66bln)

UBER